{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:02:05Z","timestamp":1791669725783,"version":"4.3.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate whether telemetric continuous glucose monitoring (CGM) in hospitalized and isolated patients with diabetes mellitus and coronavirus disease 2019 (COVID-19) is associated with better glycemic outcomes and fewer patient health care worker contacts compared to blood glucose monitoring by traditional point-of-care (POC) glucose testing and to investigate the user aspect of implementing a CGM-system in-hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A randomized controlled exploratory trial was performed on hospitalized and isolated patients with diabetes and COVID-19 from May 2020 until February 2021 at Nordsj\u00e6llands Hospital, Denmark. Participants were randomized to nonblinded telemetric CGM (as the only glucose monitoring method) or traditional POC glucose testing + blinded CGM. The primary endpoint was time in range (TIR) based on CGM data in both groups. A questionnaire about the user aspect of the CGM system was answered by health care personnel (HCP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We included 64 participants in the analysis, 31 in the CGM group and 33 in the POC glucose group. TIR median was 46% for the CGM group and 68% for the POC glucose group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.368). The mean glucose value for the CGM group was 11.1 and 10.8\u2009mmol\/L in the POC glucose group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.372). CGM was associated with fewer POC glucose measurements (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Out of 30 HCPs, 28 preferred telemetric CGM over POC glucose testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Remote glucose monitoring by CGM did not improve glycemic outcomes compared to traditional POC glucose testing, but was associated with fewer patient-personnel contacts, saving time for HCPs performing diabetes-related tasks. Most HCPs preferred CGM. The study is registered at\n                      <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">http:\/\/www.clinicaltrials.gov<\/jats:uri>\n                      (#NCT04430608).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/dia.2021.0291","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:43:05Z","timestamp":1631702585000},"page":"102-112","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":35,"title":["Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial"],"prefix":"10.1177","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-8595","authenticated-orcid":false,"given":"Carina Kirstine","family":"Klarskov","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Nephrology, Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Avlund","family":"Windum","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nephrology, Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-6168","authenticated-orcid":false,"given":"Mikkel Thor","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nephrology, Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold Matovu","family":"Dungu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Infectious Diseases, and Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-9176","authenticated-orcid":false,"given":"Andreas Kryger","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."},{"name":"Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5236-8427","authenticated-orcid":false,"given":"Birgitte","family":"Lindegaard","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Infectious Diseases, and Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-4880","authenticated-orcid":false,"given":"Ulrik","family":"Pedersen-Bjergaard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nephrology, Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-824X","authenticated-orcid":false,"given":"Peter Lommer","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nephrology, Copenhagen University Hospital \u2013 North Zealand, Hilleroed, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1438"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816632241"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818821094"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0250"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817698499"},{"key":"e_1_3_5_7_2","first-page":"FDA","article-title":"Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring during the coronavirus disease 2019 (COVID-19) Public Health Emergency","author":"US Food and Drug Administration\u2014Center for Devices and Radiological Health","year":"2020","unstructured":"US Food and Drug Administration\u2014Center for Devices and Radiological Health: Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring during the coronavirus disease 2019 (COVID-19) Public Health Emergency. Published online, 2020:Docket number: FDA-2020-D-1138.","journal-title":"Published online"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3388"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.05.014"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09630-8"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-2-49"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04872-4"},{"key":"e_1_3_5_16_2","unstructured":"World Health Organization: Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation. 2006. http:\/\/apps.who.int\/iris\/bitstream\/10665\/43588\/1\/9241594934_eng.pdf (last viewed September 1 2021)."},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0113"},{"key":"e_1_3_5_18_2","doi-asserted-by":"crossref","unstructured":"Rasmussen CE Williams CKI : Gaussian Processes in Machine Learning. Savannah GA USA: Massachusetts Institute of Technology (MIT) Press 2006.","DOI":"10.7551\/mitpress\/3206.001.0001"},{"key":"e_1_3_5_19_2","unstructured":"Abadi M Barham P Chen J et al.: Tensorflow: a system for large-scale machine learning. 12th USENIX Symp Oper Syst Des Implement (OSDI 16). 2016."},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780111005"},{"key":"e_1_3_5_21_2","unstructured":"Guideline for the treatment of adult patients with COVID-19 requiring hospitalization. Dansk Selsk Infekt. 2021. https:\/\/infmed.dk\/covid (last viewed on September 1 2021)."},{"key":"e_1_3_5_22_2","first-page":"LP","author":"Fortmann AL","unstructured":"Fortmann AL, , Spierling Bagsic SR, , Talavera L, et al.: Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a Non-ICU Hospital Setting. Diabetes Care. 2020;43:2873 LP\u20132877.","journal-title":"Diabetes Care."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1503"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0696"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820924469"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i8.1073"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.051029"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2021.0291","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2021.0291","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2021.0291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:13:22Z","timestamp":1777400002000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2021.0291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1089\/dia.2021.0291"],"URL":"https:\/\/doi.org\/10.1089\/dia.2021.0291","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}